The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
ABCG2: determining its relevance in clinical drug resistance
Open accessAbstract
Multidrug resistance is a major obstacle to successful cancer treatment. One mechanism by which cells can become resistant to chemotherapy is the expression of ABC transporters that use the energy of ATP hydrolysis to transport a wide variety of substrates across the cell membrane. There are three human ABC transporters primarily associated with the multidrug resistance phenomenon, namely Pgp, MRP1, and ABCG2. All three have broad and, to a certain extent, overlapping substrate specificities, transporting the major drugs currently used in cancer chemotherapy. ABCG2 is the most recently described of the three major multidrug-resistance pumps, and its substrates include mitoxantrone, topotecan, irinotecan, flavopiridol, and methotrexate. Despite several studies reporting ABCG2 expression in normal and malignant tissues, no trials have thus far addressed the role of ABCG2 in clinical drug resistance. This gives us an opportunity to critically review the disappointing results of past clinical trials targeting Pgp and to propose strategies for ABCG2. We need to know in which tumor types ABCG2 contributes to the resistance phenotype. We also need to develop standardized assays to detect ABCG2 expression in vivo and to carefully select the chemotherapeutic agents and clinical trial designs. This review focuses on our current knowledge about normal tissue distrubution, tumor expression profiles, and substrates and inhibitors of ABCG2, together with lessons learned from clinical trials with Pgp inhibitors. Implications of SNPs in the ABCG2 gene affecting the pharmacokinetics of substrate drugs, including many non-chemotherapy agents and ABCG2 expression in the SP population of stem cells are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Self-citationOverexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037 · cited 1×
“In 1993, Cole and colleagues cloned a gene encoding another energy-dependent transporter, the multidrug resistance-associated protein, or MRP1 (ABCC1) [5].”
BackgroundIsolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
A distinct “side population” of cells with high drug efflux capacity in human tumor cells
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, M. A., & Brenner, M. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400067101 · Cited by 1,280
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
Wang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Austin Doyle, L., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,051
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line
Kondo, T., Setoguchi, T., & Taga, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307618100 · Cited by 985
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 929
Self-citationAllikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 918
Patrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K., & Tang, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0592 · Cited by 903
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
The Role of ABC Transporters in Clinical Practice
Leonard, G. D., Fojo, T., & Bates, S. E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-411 · Cited by 817
Self-citationAllen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 814
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., & Pastan, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4538 · Cited by 686
The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme
Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., & Schuetz, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313599200 · Cited by 661
Martin, C. M., Meeson, A. P., Robertson, S. M., Hawke, T. J., Richardson, J. A., Bates, S., Goetsch, S. C., Gallardo, T. D., & Garry, D. J. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2003.09.028 · Cited by 655
Self-citationRole of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Flavonoid permeability across an in situ model of the blood–brain barrier
Youdim, K. A., Qaiser, M. Z., Begley, D. J., Rice-Evans, C. A., & Abbott, N. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.023 · Cited by 603
Human Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene Amplification
Shen, D.-W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., & Gottesman, M. M. (1986) · Science · doi:10.1126/science.3457471 · Cited by 603
Yu, L., Li-Hawkins, J., Hammer, R. E., Berge, K. E., Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216001 · Cited by 596
Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., & Mori, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0282 · Cited by 569
Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., & Bates, S. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2011 · Cited by 538
Self-citationZhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., & Sorrentino, B. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192276999 · Cited by 502
Rabindran, S. K., Ross, D. D., Doyle, L. A., Yang, W., & Greenberger, L. M. (2000) · PubMed · Cited by 487
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487
Kruijtzer, C. M. F., Beijnen, J. H., Rosing, H., ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M., & Schellens, J. H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.116 · Cited by 464
ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells
Bunting, K. D. (2002) · STEM CELLS · doi:10.1002/stem.200011 · Cited by 458
Imai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., Miki, Y., & Sugimoto, Y. (2002) · PubMed · Cited by 442
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
Self-citationJonker, J. W., Merino, G., Musters, S., van Herwaarden, A. E., Bolscher, E., Wagenaar, E., Mesman, E., Dale, T. C., & Schinkel, A. H. (2005) · Nature Medicine · doi:10.1038/nm1186 · Cited by 423
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L., & Barrand, M. A. (2002) · NeuroReport · doi:10.1097/00001756-200211150-00014 · Cited by 419
Burger, H., van Tol, H., Boersma, A. W. M., Brok, M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2004) · Blood · doi:10.1182/blood-2004-04-1398 · Cited by 417
Choudhuri, S., & Klaassen, C. D. (2006) · International Journal of Toxicology · doi:10.1080/10915810600746023 · Cited by 415
Structural, mechanistic and clinical aspects of MRP1
Hipfner, D. R., Deeley, R. G., & Cole, S. P. C. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00168-6 · Cited by 412
Pharmacological Strategies for Overcoming Multidrug Resistance
Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 393
Beck, W. T., Grogan, T. M., Willman, C. L., Cordon‐Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., et al. (1996) · PubMed · Cited by 384
Self-citationMutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T. A., Runge, S., Risbood, M., Poruchynsky, M. S., & Bates, S. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601370 · Cited by 368
Self-citationFlavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport
Zhang, S., Yang, X., & Morris, M. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1208 · Cited by 359
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
Cascorbi, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.009 · Cited by 355
Allen, J. D., Brinkhuis, R. F., Wijnholds, J., & Schinkel, A. H. (1999) · PubMed · Cited by 353
Breedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2416 · Cited by 351
Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C., & Doyle, L. A. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.429 · Cited by 350
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
Robey, R. W., Steadman, K., Polgar, O., Morisaki, K., Blayney, M., Mistry, P., & Bates, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3298 · Cited by 350
Self-citationRobey, R. W., Medina-Pérez, W. Y., Nishiyama, K., Lahusen, T. J., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., & Bates, S. E. (2001) · PubMed · Cited by 341
Self-citationBurger, H., Foekens, J. A., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2003) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 341
High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter
Özvegy-Laczka, C., Hegedűs, T., Várady, G., Ujhelly, O., Schuetz, J. D., Váradi, A., Kéri, G., Őrfi, L., Német, K., & Sarkadi, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1485 · Cited by 340
Multipotent Stem Cells in Human Corneal Stroma
Du, Y., Funderburgh, M. L., Mann, M. M., SundarRaj, N., & Funderburgh, J. L. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0256 · Cited by 335
Cisternino, S., Mercier, C., Bourasset, F., Roux, F., & Scherrmann, J.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2033 · Cited by 329
Houghton, P. J., Germain, G. S., Harwood, F. C., Schuetz, J. D., Stewart, C. F., Buchdunger, E., & Traxler, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3344 · Cited by 323
Mizuarai, S., Aozasa, N., & Kotani, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.11669 · Cited by 318
Chen, Z., Robey, R. W., Belinsky, M. G., Shchaveleva, I., Ren, X. Q., Sugimoto, Y., Ross, D. D., Bates, S. E., & Kruh, G. D. (2003) · PubMed · Cited by 305
Self-citationRabindran, S. K., He, H., Singh, M. S., Brown, E., Collins, K., Annable, T., & Greenberger, L. M. (1998) · PubMed · Cited by 305
Watkins, P. B., Wrighton, S. A., Barnett, J. L., Lown, K. S., Kunze, K. L., Thummel, K. E., & Kolars, J. C. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/n8xg-qs69 · Cited by 304
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
de Bruin, M., Miyake, K., Litman, T., Robey, R., & Bates, S. E. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00182-2 · Cited by 298
Self-citationFunctional and molecular characterisation of mammary side population cells
Alvi, A. J., Clayton, H., Joshi, C., Enver, T., Ashworth, A., Vivanco, M. A. M., Dale, T. C., & Smalley, M. J. (2002) · Breast Cancer Research · doi:10.1186/bcr547 · Cited by 289
Imai, Y., Tsukahara, S., Asada, S., & Sugimoto, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0078 · Cited by 280
Diestra, J. E., Scheffer, G. L., Català, I., Maliepaard, M., Schellens, J. H. M., Scheper, R. J., Germà‐Lluch, J. R., & Izquierdo, M. A. (2002) · The Journal of Pathology · doi:10.1002/path.1203 · Cited by 275
Side population cells and Bcrp1 expression in lung
Summer, R., Kotton, D. N., Sun, X., Ma, B., Fitzsimmons, K., & Fine, A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2003 · Cited by 275
van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2003) · PubMed · Cited by 269
FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA
Kobayashi, D., Ieiri, I., Hirota, T., Takane, H., Maegawa, S., Kigawa, J., Suzuki, H., Nanba, E., Oshimura, M., Terakawa, N., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001628 · Cited by 268
Functional Analysis of SNPs Variants of BCRP/ABCG2
Kondo, C., Suzuki, H., Itoda, M., Ozawa, S., Sawada, J.-I., Kobayashi, D., Ieiri, I., Mine, K., Ohtsubo, K., & Sugiyama, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045245.21637.d4 · Cited by 264
Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C. H. M., Robey, R. W., Pommier, Y. G., Fojo, T., & Bates, S. E. (1999) · PubMed · Cited by 263
Self-citationInvolvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
Ross, D. D., Karp, J. E., Chen, T. T., & Doyle, L. A. (2000) · Blood · doi:10.1182/blood.v96.1.365 · Cited by 250
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.
Volk, E. L., Farley, K. M., Wu, Y. F., Li, F., Robey, R. W., & Schneider, E. (2002) · PubMed · Cited by 248
Self-citationA functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)
Robey, R. W., Honjo, Y., van de Laar, A., Miyake, K., Regis, J. T., Litman, T., & Bates, S. E. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00308-x · Cited by 245
Self-citationBreast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
Kawabata, S., Oka, M., Shiozawa, K., Tsukamoto, K., Nakatomi, K., Soda, H., Fukuda, M., Ikegami, Y., Sugahara, K., Yamada, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4267 · Cited by 242
Yoh, K., Ishii, G., Yokose, T., Minegishi, Y., Tsuta, K., Goto, K., Nishiwaki, Y., Kodama, T., Suga, M., & Ochiai, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0937-3 · Cited by 242
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype*1
SPARREBOOM, A. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.03.003 · Cited by 241
Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
Qadir, M., O'Loughlin, K. L., Fricke, S. M., Williamson, N. A., Greco, W. R., Minderman, H., & Baer, M. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1725 · Cited by 236
Budak, M. T., Alpdogan, O. S., Zhou, M., Lavker, R. M., Akinci, M. A. M., & Wolosin, J. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02279 · Cited by 232
Maliepaard, M., van Gastelen, M. A., Tohgo, A., Hausheer, F. H., van Waardenburg, R. C. A. M., de Jong, L. A., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2001) · PubMed · Cited by 231
Single nucleotide polymorphisms modify the transporter activity of ABCG2
Morisaki, K., Robey, R. W., Özvegy-Laczka, C., Honjo, Y., Polgar, O., Steadman, K., Sarkadi, B., & Bates, S. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0931-x · Cited by 230
Self-citationMerino, G., Jonker, J. W., Wagenaar, E., van Herwaarden, A. E., & Schinkel, A. H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010439 · Cited by 228
Interaction of the breast cancer resistance protein with plant polyphenols
Cooray, H. C., Janvilisri, T., van Veen, H. W., Hladky, S. B., & Barrand, M. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.040 · Cited by 226
Steinbach, D., Sell, W., Voigt, A., Hermann, J., Zintl, F., & Sauerbrey, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402541 · Cited by 226
Bailey-Dell, K. J., Hassel, B., Doyle, L. A., & Ross, D. D. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00270-6 · Cited by 225
Elkind, N. B., Szentpétery, Z., Apáti, A., Özvegy-Laczka, C., Várady, G., Ujhelly, O., Szabó, K., Homolya, L., Váradi, A., Buday, L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3303 · Cited by 225
Erlichman, C., Boerner, S. A., Hallgren, C. G., Spieker, R. S., Wang, X., James, C. D., Scheffer, G. L., Maliepaard, M., Ross, D. D., Bible, K. C., et al. (2001) · PubMed · Cited by 224
Chen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., & Fojo, A. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38781-2 · Cited by 221
Ee, P. L. R., Kamalakaran, S., Tonetti, D., He, X., Ross, D. D., & Beck, W. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3583 · Cited by 217
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk, E. L., & Schneider, E. (2003) · PubMed · Cited by 215
Lechner, A., Leech, C. A., Abraham, E. J., Nolan, A. L., & Habener, J. F. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00275-9 · Cited by 210
Limtrakul, P., Chearwae, W., Shukla, S., Phisalphong, C., & Ambudkar, S. V. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9302-8 · Cited by 208
de Jong, F. A., Marsh, S., Mathijssen, R. H. J., King, C., Verweij, J., Sparreboom, A., & McLeod, H. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0144 · Cited by 207
ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy
Robey, R. W., Steadman, K., Polgar, O., & Bates, S. E. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1440 · Cited by 204
Self-citationÖzvegy, C., Váradi, A., & Sarkadi, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207857200 · Cited by 204
Expression and functional characterization of ABCG2 in brain endothelial cells and vessels
Zhang, W., Mojsilovic-Petrovic, J., Andrade, M. F., Zhang, H., Ball, M., & Stanimirovic, D. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1131fje · Cited by 204
Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice
Stewart, C. F., Leggas, M., Schuetz, J. D., Panetta, J. C., Cheshire, P. J., Peterson, J., Daw, N., Jenkins, J. J., Gilbertson, R., Germain, G. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0096 · Cited by 203
Merino, G., Álvarez, A. I., Pulido, M. M., Molina, A. J., Schinkel, A. H., & Prieto, J. G. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008219 · Cited by 199
Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues
Fetsch, P. A., Abati, A., Litman, T., Morisaki, K., Honjo, Y., Mittal, K., & Bates, S. E. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.024 · Cited by 197
Self-citationGefitinib reverses breast cancer resistance protein–mediated drug resistance
Yanase, K., Tsukahara, S., Asada, S., Ishikawa, E., Imai, Y., & Sugimoto, Y. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1119.3.9 · Cited by 196
Ahmed-Belkacem, A., Pozza, A., Muñoz-Martínez, F., Bates, S. E., Castanys, S., Gamarro, F., Di Pietro, A., & Pérez-Victoria, J. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1817 · Cited by 196
Self-citationKönig, J., Hartel, M., Nies, A. T., Martignoni, M. E., Guo, J., Büchler, M. W., Friess, H., & Keppler, D. (2005) · International Journal of Cancer · doi:10.1002/ijc.20831 · Cited by 194
Matsushima, S., Maeda, K., Kondo, C., Hirano, M., Sasaki, M., Suzuki, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085589 · Cited by 190
Wilson, C. S. (2006) · Blood · doi:10.1182/blood-2004-12-4633 · Cited by 190
Press, H. (2001) · Cited by 190
ABCG2 expression, function, and promoter methylation in human multiple myeloma
Turner, J. G., Gump, J. L., Zhang, C., Cook, J. M., Marchion, D., Hazlehurst, L., Munster, P., Schell, M. J., Dalton, W. S., & Sullivan, D. M. (2006) · Blood · doi:10.1182/blood-2005-10-009084 · Cited by 189
Nakatomi, K., Yoshikawa, M., Oka, M., Ikegami, Y., Hayasaka, S., Sano, K., Shiozawa, K., Kawabata, S., Soda, H., Ishikawa, T., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5850 · Cited by 189
Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias
Benderra, Z., Faussat, A.-M., Sayada, L., Perrot, J.-Y., Chaoui, D., Marie, J.-P., & Legrand, O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0795 · Cited by 188
Zhang, S., Yang, X., Coburn, R. A., & Morris, M. E. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.017 · Cited by 188
Nakamura, Y., Oka, M., Soda, H., Shiozawa, K., Yoshikawa, M., Itoh, A., Ikegami, Y., Tsurutani, J., Nakatomi, K., Kitazaki, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-2417 · Cited by 177
van den Heuvel-Eibrink, M., Wiemer, E., Prins, A., Meijerink, J., Vossebeld, P., van der Holt, B., Pieters, R., & Sonneveld, P. (2002) · Leukemia · doi:10.1038/sj.leu.2402496 · Cited by 175
Scheffer, G. L., Maliepaard, M., Pijnenborg, A. C. L. M., van Gastelen, M. A., de Jong, M. C., Schroeijers, A. B., van der Kolk, D. M., Allen, J. D., Ross, D. D., van der Valk, P., et al. (2000) · PubMed · Cited by 171
Cancer stem cell characteristics in retinoblastoma.
Seigel, G. M., Campbell, L. M., Narayan, M., & Gonzalez-Fernandez, F. (2005) · PubMed · Cited by 171
MRP Subfamily Transporters and Resistance to Anticancer Agents
Kruh, G. D., Zeng, H., Rea, P. A., Liu, G., Chen, Z.-S., Lee, K., & Belinsky, M. G. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012827221844 · Cited by 170
Minderman, H., O’Loughlin, K. L., Pendyala, L., & Baer, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0914-3 · Cited by 170
Estrogen-Mediated Post transcriptional Down-regulation of Breast Cancer Resistance Protein/ABCG2
Imai, Y., Ishikawa, E., Asada, S., & Sugimoto, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.596.65.2 · Cited by 169
Huang, L., Wang, Y., & Grimm, S. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007534 · Cited by 169
Lassalle, B., Bastos, H., Louis, J. P., Riou, L., Testart, J., Dutrillaux, B., Fouchet, P., & Allemand, I. (2003) · Development · doi:10.1242/dev.00918 · Cited by 166
Bart, J., Hollema, H., Groen, H. J. M., de Vries, E. G. E., Hendrikse, N. H., Sleijfer, D. T., Wegman, T. D., Vaalburg, W., & van der Graaf, W. T. A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.010 · Cited by 164
Effect of ABCG2 genotype on the oral vioavailability of topotecan
Sparreboom, A., Loos, W. J., Burger, H., Sissung, T. M., Verweij, J., Figg, II, Nooter, K., & Gelderblom, H. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.6.1731 · Cited by 162
Herwaarden, A. E. V., Wagenaar, E., Karnekamp, B., Merino, G., Jonker, J. W., & Schinkel, A. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi176 · Cited by 161
Multidrug Resistance/P-Glycoprotein and Breast Cancer: Review and Meta-Analysis
Clarke, R., Leonessa, F., & Trock, B. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.09.009 · Cited by 159
Montanaro, F., Liadaki, K., Schienda, J., Flint, A., Gussoni, E., & Kunkel, L. M. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.010 · Cited by 158
Modulation of oral bioavailability of anticancer drugs: from mouse to man.
Schellens, J., Malingré, M., Kruijtzer, C., Bardelmeijer, H. A., van Tellingen, O., Schinkel, A., & Beijnen, J. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00153-6 · Cited by 153
Jonker, J. W., Freeman, J., Bolscher, E., Musters, S., Alvi, A. J., Titley, I., Schinkel, A. H., & Dale, T. C. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0150 · Cited by 153
Allen, J. D., Jackson, S. C., & Schinkel, A. H. (2002) · PubMed · Cited by 151
Regulation of BCRP/ABCG2 expression by progesterone and 17β-estradiol in human placental BeWo cells
Wang, H., Zhou, L., Gupta, A., Vethanayagam, R. R., Zhang, Y., Unadkat, J. D., & Mao, Q. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00397.2005 · Cited by 149
Dietel, M., Arps, H., Lage, H., & Niendorf, A. (1990) · PubMed · Cited by 149
Complement-Mediated Mechanisms in Anti-GD2 Monoclonal Antibody Therapy of Murine Metastatic Cancer
Imai, M., Landen, C., Ohta, R., Cheung, N. V., & Tomlinson, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1894 · Cited by 139
Nakagawa, M., Schneider, E., Dixon, K. H., Horton, J., Kelley, K., Morrow, C., & Cowan, K. H. (1992) · PubMed · Cited by 136
van der Kolk, D. M., Vellenga, E., Scheffer, G. L., Müller, M. M., Bates, S. E., Scheper, R. J., & de Vries, E. G. E. (2002) · Blood · doi:10.1182/blood.v99.10.3763 · Cited by 133
Self-citationLitman, T., Jensen, U., Hansen, A., Covitz, K.-M., Zhan, Z., Fetsch, P. A., Abati, A. D., Hansen, P. B., Horn, T. D., Skovsgaard, T., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00492-3 · Cited by 131
Self-citationThe Role of Half-Transporters in Multidrug Resistance
Bates, S. E., Robey, R. W., Miyake, K., Rao, K. V., Ross, D. D., & Litman, T. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012879205914 · Cited by 130
Self-citationBCRP Transports Dipyridamole and is Inhibited by Calcium Channel Blockers
Zhang, Y., Gupta, A., Wang, H., Zhou, L., Vethanayagam, R. R., Unadkat, J. D., & Mao, Q. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8384-4 · Cited by 130
Chearwae, W., Shukla, S., Limtrakul, P., & Ambudkar, S. V. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0087 · Cited by 130
Prendergast, G. C. (2004) · Wiley eBooks · doi:10.1002/047165616x · Cited by 129
Woodworth, C. D., Michael, E., Marker, D. F., Allen, S. E., Smith, L., & Nees, M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0238 · Cited by 129
Allen, J. D., Dort, S. C. V., Buitelaar, M., van Tellingen, O., & Schinkel, A. H. (2003) · PubMed · Cited by 129
Sesink, A. L. A., Arts, I. C. W., de Boer, V. C. J., Breedveld, P., Schellens, J. H. M., Hollman, P. C. H., & Rüssel, F. G. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009753 · Cited by 128
Erratum to: Functional and molecular characterisation of mammary side population cells
Alvi, A. J., Clayton, H., Joshi, C., Enver, T., Ashworth, A., Vivanco, M. D., Dale, T. C., & Smalley, M. J. (2002) · Breast Cancer Research · doi:10.1186/bcr563 · Cited by 127
Gupta, A., Dai, Y., Vethanayagam, R. R., Hébert, M. F., Thummel, K. E., Unadkat, J. D., Ross, D. D., & Mao, Q. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0173-6 · Cited by 126
Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma
To, K. K. W., Zhan, Z., & Bates, S. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00650-06 · Cited by 126
Self-citationTRANSPORT OF ANTHELMINTIC BENZIMIDAZOLE DRUGS BY BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2)
Merino, G., Jonker, J. W., Wagenaar, E., Pulido, M. M., Molina, A. J., Álvarez, A. I., & Schinkel, A. H. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003319 · Cited by 126
Mitomo, H., Kato, R., Ito, A., Kasamatsu, S., Ikegami, Y., Kii, I., Kudō, A., Kobatake, E., SUMINO, Y., & Ishikawa, T. (2003) · Biochemical Journal · doi:10.1042/bj20030150 · Cited by 123
Low levels of ABCG2 expression in adult AML blast samples
Abbott, B. L., Colapietro, A.-M., Barnes, Y., Marini, F. C., Andreeff, M., & Sorrentino, B. P. (2002) · Blood · doi:10.1182/blood-2002-01-0271 · Cited by 121
Expression of the breast cancer resistance protein in breast cancer.
Faneyte, I. F., Kristel, P., Maliepaard, M., Scheffer, G. L., Scheper, R. J., Schellens, J. H. M., & van de Vijver, M. J. (2002) · PubMed · Cited by 119
BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells
Yang, C.-H., Schneider, E., Kuo, M., Volk, E. L., Rocchi, E., & Chen, Y. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00396-8 · Cited by 113
Schellens, J. H. M., Maliepaard, M., Scheper, R. J., Scheffer, G. L., Jonker, J. W., Smit, J. W., Beijnen, J. H., & Schinkel, A. H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07037.x · Cited by 111
Sugimoto, Y., Tsukahara, S., Imai, Y., Sugimoto, Y., Ueda, K., & Tsuruo, T. (2003) · PubMed · Cited by 110
Reversal of breast cancer resistance protein–mediated drug resistance by tryprostatin A
Woehlecke, H., Osada, H., Herrmann, A., & Lage, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11444 · Cited by 108
Expression and functional analyses of breast cancer resistance protein in lung cancer.
Kawabata, S., Oka, M., Soda, H., Shiozawa, K., Nakatomi, K., Tsurutani, J., Nakamura, Y., Doi, S., Kitazaki, T., Sugahara, K., et al. (2003) · PubMed · Cited by 107
Shukla, S., Robey, R. W., Bates, S. E., & Ambudkar, S. V. (2006) · Biochemistry · doi:10.1021/bi060552f · Cited by 107
Self-citationFujino, H., Saito, T., Ogawa, S.-I., & Kojima, J. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.10.0009 · Cited by 104
BCRP mRNA expression v. clinical outcome in 40 adult AML patients
Uggla, B., Ståhl, E., Wågsäter, D., Paul, C., Karlsson, M. G., Sirsjö, A., & Tidefelt, U. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.06.004 · Cited by 103
Komatani, H., Kotani, H., Hara, Y., Nakagawa, R., Matsumoto, M., Arakawa, H., & Nishimura, S. (2001) · PubMed · Cited by 98
Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia
Sauerbrey, A., Sell, W., Steinbach, D., Voigt, A., & Zintl, F. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03550.x · Cited by 97
Bates, S. E., Medina-Pérez, W. Y., Kohlhagen, G., Antony, S., Nadjem, T., Robey, R. W., & Pommier, Y. G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063149 · Cited by 95
Self-citationŠtaud, F., Vacková, Z., Pospěchová, K., Pávek, P., Čečková, M., Libra, A., Cygalova, L. H., Nachtigal, P., & Fendrich, Z. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105023 · Cited by 95
Janvilisri, T., Shahi, S., Venter, H., Balakrishnan, L., & van Veen, H. W. (2005) · Biochemical Journal · doi:10.1042/bj20040791 · Cited by 93
Sargent, J. M., Williamson, C. J., Maliepaard, M., Elgie, A. W., Scheper, R. J., & Taylor, C. G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03122.x · Cited by 93
Knutsen, T., Rao, V. K., Ried, T., Mickley, L. A., Schneider, E., Miyake, K., Ghadimi, Β. M., Padilla‐Nash, H. M., Pack, S., Greenberger, L. M., et al. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200001)27:1<110::aid-gcc14>3.3.co;2-w · Cited by 93
Self-citationÖzvegy‐Laczka, C., Várady, G., Köblös, G., Ujhelly, O., Cervenak, J., Schuetz, J. D., Sorrentino, B. P., Koomen, G., Váradi, A., Német, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411338200 · Cited by 92
Özvegy‐Laczka, C., Köblös, G., Sarkadi, B., & Váradi, A. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.11.005 · Cited by 90
Yang, J. C., Horton, J. K., Cowan, K. H., & Schneider, E. (1995) · PubMed · Cited by 89
Zhang, S., Wang, X., Sagawa, K., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002501 · Cited by 89
Jekerle, V., Klinkhammer, W., Scollard, D. A., Breitbach, K., Reilly, R. M., Piquette‐Miller, M., & Wiese, M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21827 · Cited by 83
Diestra, J. E., Condom, E., del Muro, X. G., Scheffer, G. L., Pérez-Piteira, J., Zurita, A. J., MUÑOZ-SEGUÍ, J., Vigués, F., Scheper, R. J., Capellá, G., et al. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000074710.96154.c9 · Cited by 81
Miwa, M., Tsukahara, S., Ishikawa, E., Asada, S., Imai, Y., & Sugimoto, Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.11484 · Cited by 80
Modulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application
Kuppens, I. E. L. M., Breedveld, P., Beijnen, J. H., & Schellens, J. H. M. (2005) · Cancer Investigation · doi:10.1081/cnv-58823 · Cited by 79
Unfavourable expression of pharmacologic markers in mucinous colorectal cancer
Glasgow, S. C., Yu, J., Carvalho, L. P., Shannon, W. D., Fleshman, J. W., & McLeod, H. L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602330 · Cited by 74
Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells
Futscher, B. W., Abbaszadegan, M. R., Domann, F. E., & Dalton, W. S. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90538-x · Cited by 73
van der Pol, M. A., Broxterman, H. J., Pater, J. M., Feller, N., van der Maas, M., Weijers, G. W. D., Scheffer, G. L., Jd, A., Scheper, R. J., van Loevezijn, A., et al. (2003) · PubMed · Cited by 71
Ejendal, K. F. K., Diop, N. K., Schweiger, L. C., & Hrycyna, C. A. (2006) · Protein Science · doi:10.1110/ps.051998406 · Cited by 69
Yoshikawa, M., Ikegami, Y., Sano, K., Yoshida, H., Mitomo, H., Sawada, S., & Ishikawa, T. (2004) · PubMed · Cited by 66
Mouse models of human breast cancer: evolution or convolution?
Green, J. (2003) · Breast Cancer Research · doi:10.1186/bcr660 · Cited by 65
Suvannasankha, A., Minderman, H., O’Loughlin, K. L., Nakanishi, T., Ford, L. A., Greco, W. R., Wetzler, M., Ross, D. D., & Baer, M. R. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05211.x · Cited by 63
Side Population Cells Derived from Adult Human Liver Generate Hepatocyte-like Cells In Vitro
Hussain, S. Z., Strom, S. C., Kirby, M., Burns, S., Langemeijer, S. M. C., Ueda, T., Hsieh, M. M., & Tisdale, J. F. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2933-x · Cited by 61
ABCG2 Harboring the Gly482 Mutation Confers High-Level Resistance to Various Hydrophilic Antifolates
Shafran, A., Ifergan, I., Bram, E. E., Jansen, G., Kathmann, I., Peters, G. J., Robey, R. W., Bates, S. E., & Assaraf, Y. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4547 · Cited by 61
Self-citationAust, S., Obrist, P., Jaeger, W., Klimpfinger, M., Tucek, G., Wrba, F., Penner, E., & Thalhammer, T. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700127 · Cited by 59
A Phase II Study of Thalidomide in Advanced Metastatic Renal Cell Carcinoma
Minor, D. R., Monroe, D., Damico, L. A., Meng, G., Suryadevara, U., & Elias, L. (2002) · Investigational New Drugs · doi:10.1023/a:1020669705369 · Cited by 48
Mantovani, G., Macciò, A., Pisano, M., Versace, R., Lai, P., Esu, S., Massa, E., Ghiani, M., Dessì, D., Melis, G. B., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<817::aid-ijc20>3.0.co;2-3 · Cited by 45
Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas
Nishiyama, K., Shirahama, T., Yoshimura, A., Sumizawa, T., Furukawa, T., Ichikawa, M., Akiyama, S.-I., & Ohi, Y. (1993) · Cancer · Cited by 45
van Hattum, A. H., Schlüper, H. M. M., Hausheer, F. H., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10434 · Cited by 43
Mickley, L. A., Jain, P. K., Miyake, K., Schriml, L. M., Rao, K., Fojo, T., Bates, S. E., & Dean, M. C. (2001) · Mammalian Genome · doi:10.1007/s003350010237 · Cited by 35
Self-citationBraun, A., Stark, K., Dirsch, O., Hilger, R. A., Seeber, S., & Vanhoefer, U. J. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200511000-00009 · Cited by 32
Robey, R. W., Fetsch, P. A., Polgár, O., Dean, M. C., & Bates, S. E. (2006) · Research in Veterinary Science · doi:10.1016/j.rvsc.2006.04.003 · Cited by 25
Self-citationEffects of ATP depletion and phosphate analogues on P‐glycoprotein conformation in live cells
Goda, K., Nagy, H., Mechetner, E. B., Cianfriglia, M., & Szabó, G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02929.x · Cited by 19
Cited by
ABC transporters in cancer: more than just drug efflux pumps
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2789 · Cited by 1,018
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Bleau, A.-M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., & Holland, E. C. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.007 · Cited by 808
Kathawala, R. J., Gupta, P., Ashby, C. R., & Chen, Z.-S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2014.11.002 · Cited by 777
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Metadata
- Authors
- Robey, R. W., Polgar, O., Deeken, J., To, K. W., & Bates, S. E.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2007-02-24
- Volume
- 26
- Issue
- 1
- Pages
- 39-57
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2055757796
- Cited by
- 387
- References
- 187
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.